BIO Stock Price Prediction 2026-2027
AI-powered forecast for Bio-Rad Laboratories Inc
Based on Wall Street consensus estimate - Medium Confidence
Current Price
$323.00
Price Targets for 2027
Bear Case
$334.53
+3.6%
Base Case
$348.00
+7.7%
Bull Case
$361.47
+11.9%
Prediction Tracking
Coming Soon for BIO
Tracking begins January 2026
We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.
Upcoming Events for BIO
Key Factors Influencing BIO Stock
Bullish Factors
- Revenue growth of 0.0% year-over-year
- Market position and competitive advantages
Risk Factors
- Market volatility and macroeconomic factors
- Competitive pressures in Medical Devices
Prediction Methodology
These predictions are based on the Wall Street consensus price target of $348.00.
Bull and bear cases are calculated with a reasonable spread around the consensus based on historical volatility.
Get Real-Time Analysis
Access live data, AI insights, and detailed valuations for BIO
Frequently Asked Questions
What is BIO stock price today?
BIO (Bio-Rad Laboratories Inc) stock is trading at $323.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is BIO stock going up or down today?
BIO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy BIO stock now?
The decision to buy BIO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is BIO a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for BIO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is BIO stock overvalued or undervalued?
Use our DCF valuation calculator to determine if BIO is overvalued or undervalued based on fundamental analysis and future cash flow projections.
What is BIO's P/E ratio?
P/E ratio data for BIO will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.
What is BIO's market cap?
BIO (Bio-Rad Laboratories Inc) has a market capitalization of $8.73 billion, making it a small-cap stock.
What is BIO's price to book ratio?
BIO trades at a price-to-book (P/B) ratio of 1.30, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Does BIO pay dividends?
BIO does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.
What is BIO's dividend yield?
BIO does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.
Is BIO stock a good long-term investment?
BIO's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.
What is BIO's revenue growth rate?
BIO has shown revenue growth of 0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.
Is BIO profitable?
BIO is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.
What are the risks of investing in BIO?
Key risks for BIO include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.
How does BIO compare to its competitors?
Compare BIO to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize BIO's performance and positioning.
What is BIO's stock price target for 2026?
Our AI model provides price targets for BIO based on fundamental analysis: Bull case $419.90 (+30%), Base case $371.45 (+15%), Bear case $290.70 (-10%). Visit our prediction page for detailed forecasts.
What do analysts say about BIO?
Wall Street analysts provide ratings (buy/hold/sell) and price targets for BIO. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.
When is BIO's next earnings report?
BIO reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.